Danone S.A. (BN.PA) Bundle
Trace Danone's century-long journey from Isaac Carasso's 1919 Barcelona yogurt experiment to the modern global food giant born from the 1973 merger of Gervais and BSN and renamed Danone in 1994, and you'll see a company that today reports sales of €27.6 billion (2023) and €27.4 billion (2024), employs over 96,000 people worldwide, and operates top brands like Activia, Alpro, evian and Aptamil across more than 120 markets; in 2025 Danone pushed its financial and sustainability agenda with a target for global B Corp™ certification, a completed share buyback of 2.7 million shares for €192 million, issuance of an €800 million 8‑year bond at a 3.438% coupon, and reported a recurring operating margin of 13.2% alongside €1.2 billion in free cash flow while managing net debt of €9.1 billion (up from €8.6 billion at end‑2024) as it pursues 3-5% like‑for‑like sales growth under its Renew strategy.
Danone S.A. (BN.PA): Intro
Danone S.A. (BN.PA) is a global food‑and‑beverage company founded on a yogurt legacy and now diversified across dairy & plant‑based, specialized nutrition and water. The group combines a long corporate history with contemporary sustainability ambitions and global scale. History and milestones- 1919 - Isaac Carasso founded Danone in Barcelona, introducing yogurt to the Spanish market.
- 1966 - Boussois‑Souchon‑Neuvesel (BSN) was established in France; later expanded through acquisitions.
- 1973 - BSN merged with Gervais Danone to create the lineage of today's Danone.
- 1994 - The company adopted the Danone name, aligning corporate identity with its leading consumer brand.
- 2023 - Group sales reached €27.6 billion, consolidating Danone's global leadership in food & beverage.
- 2024 - Sales were €27.4 billion, maintaining a strong market presence amid a complex macroeconomic backdrop.
- 2025 (ambition) - Danone aims to obtain B Corp™ certification globally, reflecting commitments to social and environmental performance.
- Business segments:
- Essentials: Dairy & Plant‑Based (yogurts, fresh dairy, plant alternatives).
- Specialized Nutrition: infant formula, medical nutrition and early life nutrition.
- Waters: bottled and functional waters, both global and local brands.
- Revenue drivers: branded consumer goods, geographic diversification (Europe, North America, Emerging Markets), product innovation (plant‑based, probiotics, premix nutrition), and pricing/mix improvements.
- Distribution: supermarket chains, pharmacy and healthcare channels (for specialized nutrition), e‑commerce and foodservice partnerships.
| Metric | 2023 | 2024 |
|---|---|---|
| Net sales | €27.6 billion | €27.4 billion |
| Employees (approx.) | ~99,000 | ~99,000 |
| Primary segments - sales split (approx.) | EDP €13.4bn / Specialized Nutrition €8.2bn / Waters €5.9bn | Proportionally similar mix |
- Publicly listed on Euronext Paris (ticker: BN.PA) with a widely held shareholder base composed of institutional investors, retail investors and foundations.
- Governance framework emphasizes sustainability targets, with board oversight of ESG, long‑term strategy and executive compensation aligned with social and environmental KPIs.
- Premiumization and innovation in dairy & plant‑based categories to capture margin and consumer trends.
- Expansion in early‑life and medical nutrition where higher growth and margins are typical.
- Cost and portfolio optimization (SKU rationalization, supply‑chain efficiency) to protect profitability in low‑growth markets.
- Accelerated sustainability actions (packaging, regenerative agriculture, emissions reduction) tied to the B Corp™ ambition.
Danone S.A. (BN.PA): History
Danone S.A. is a Paris-listed multinational food-products corporation with origins tracing back to the early 20th century through mergers and acquisitions of dairy and bottled water businesses. Over decades it expanded into specialized nutrition and plant-based foods, positioning itself as a global leader in consumer staples.- Listed on Euronext Paris and a component of the CAC 40 index.
- Available to U.S. investors via an ADR program on the OTCQX platform.
- Global footprint with operations across Europe, the Americas, Asia, Africa and Oceania.
Ownership Structure & Capital Markets
- Publicly traded free float complemented by strategic and institutional shareholders.
- Employee share plans and long-term incentive programs contribute to capital increases; Danone actively manages dilution through buybacks.
- Access to debt markets demonstrated by frequent bond issuance and diversified maturities.
| Metric | Value | Period / Note |
|---|---|---|
| Employees | 96,000+ | As of 2023 |
| Net debt | €9.1 billion | 2025 (up from €8.6bn at 31 Dec 2024) |
| Bond issuance | €800 million, 8-year, 3.438% coupon | Issued 2025; listed on Euronext Paris |
| Share buyback | 2.7 million shares for €192 million | Completed 2025 |
| Stock exchange | Euronext Paris (CAC 40) | Primary listing |
| ADR availability | OTCQX | For international investors |
How It Works & Revenue Drivers
- Core business segments: Dairy & Plant-Based, Waters, Early Life & Medical Nutrition.
- Revenue mix driven by branded consumer goods sold through retail, foodservice, and e-commerce channels.
- Cash generation supports dividends, buybacks and selective M&A; strong free cash flow helped offset dividend-driven net debt increase in 2025.
For a detailed deep-dive, see: Danone S.A.: History, Ownership, Mission, How It Works & Makes Money
Danone S.A. (BN.PA): Ownership Structure
Danone's corporate mission is to "bring health through food to as many people as possible," with a long-term emphasis on measurable nutritional, social and environmental impact. The company pursues this mission through nutrition research, portfolio choices focused on dairy & plant-based, early life nutrition and medical nutrition, and an explicit sustainability agenda captured in its Renew strategy to restore growth, competitiveness and long‑term value creation.- Mission: Bring health through food to as many people as possible.
- Strategic focus: Renew strategy - restore growth, competitiveness and value creation.
- Sustainability target: Global B Corp™ certification aimed for 2025.
- Index & ratings presence: component of MSCI ESG Indexes, FTSE4Good, Bloomberg Gender‑Equality Index, Moody's/Sustainalytics coverage and ranked in the Access to Nutrition Index.
| Metric | Value |
|---|---|
| Revenue (FY) | ≈ €25.5 billion |
| Recurring operating income / EBIT | ≈ €2.2 billion |
| Net income (attributable) | ≈ €1.2-1.5 billion |
| Employees | ≈ 95,000-100,000 |
| Market listing | Euronext Paris (BN.PA) |
| Target: B Corp | Global certification target - 2025 |
- Free float / institutional investors: majority of outstanding shares (roughly 60-75%).
- Strategic/major shareholders: a small number of large stakeholders hold single‑digit to low‑teens percentages (historic notable names include large family/industrial shareholders and diversified holding companies; positions have shifted following past takeover interest).
- Employee/shareholder programs & treasury stock: minor but meaningful (typically a few percent total).
- Product mix: fresh dairy and plant‑based products, specialized nutrition (early life & medical), waters - sold across retail, foodservice and medical channels.
- R&D & nutrition investment: ongoing investment in clinical research, formulation and sustainable sourcing to support premium pricing and innovation-led growth.
- Geographic diversification: strong footprint in Europe, Americas, Asia & Africa - local brands + global platforms.
- Revenue drivers: product premiumization, portfolio optimization, price/mix and targeted cost savings under Renew to improve margins and free cash flow.
Danone S.A. (BN.PA): Mission and Values
How It Works - business model and operating structure- Three health-focused, fast-growing categories: Essential Dairy & Plant-Based (EDP), Waters, and Specialized Nutrition (including early life and medical nutrition).
- Portfolio of leading global and local brands: Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, plus regional champions across Europe, Asia, Africa and the Americas.
- Products sold in over 120 markets through mixed channels: modern retail, traditional trade, e‑commerce, foodservice and institutional sales.
- Global workforce of nearly 90,000 employees supporting R&D, manufacturing, commercial, and supply‑chain operations.
- Publicly listed company on Euronext Paris (ticker: BN.PA); widely held by institutional investors and retail shareholders.
- Major institutional holders typically include asset managers and sovereign/institutional funds (e.g., Amundi, BlackRock, Vanguard and similar large investors), with free float enabling active trading and index inclusion.
- Corporate governance: board and executive management focused on ESG, portfolio premiumization, and margin recovery initiatives.
- Mission: to bring health through food to as many people as possible by offering trusted, science‑backed, accessible nutrition and hydration solutions.
- Core values emphasize health, social responsibility, environmental stewardship, and partnerships with farmers and suppliers to drive regenerative agriculture and lower carbon footprint.
- Strategic priorities align portfolio premiumization, innovation in plant‑based and specialized nutrition, geographic focus, and operational efficiency.
- Product sales across three pillars: EDP (yoghurts, fermented milk, plant alternatives), Waters (still and sparkling bottled water brands), and Specialized Nutrition (infant formula, medical nutrition, clinical products).
- Revenue uplift levers: pricing & mix (premiumization), innovation (new SKUs, plant‑based expansion), geographic expansion, channel mix shift to e‑commerce and value‑added formats, and cost/productivity programs to protect margins.
- Profitability supported by brand equity (allowing premium pricing), scale manufacturing and distribution, and margin recovery initiatives targeting recurring operating income growth.
| Metric | Value / Note |
|---|---|
| Like‑for‑like sales growth (2025 guidance) | 3% to 5% |
| Recurring operating margin (2025) | 13.2% |
| Free cash flow (2025) | €1.2 billion |
| Markets served | More than 120 countries |
| Employees | Nearly 90,000 |
| Primary revenue streams | EDP, Waters, Specialized Nutrition |
| Typical corporate levers | Pricing & mix, innovation, channel shift, cost productivity |
- Recurring operating income targeted to outpace sales growth, driven by margin programs and selective reinvestment behind high‑growth brands and categories.
- Cash generation (FCF €1.2bn in 2025) supports debt servicing, share buybacks/dividends where appropriate, and M&A aimed at high‑margin, health‑oriented businesses.
- Ongoing investment in R&D, sustainability (packaging, water stewardship, regenerative agriculture) and digital to accelerate direct‑to‑consumer and e‑commerce capabilities.
Danone S.A. (BN.PA): How It Works
Danone S.A. (BN.PA) is a global food and beverage company that generates revenue primarily through three product categories: Essential Dairy & Plant-Based (EDP), Waters, and Specialized Nutrition. Its business model combines branded consumer packaged goods, geographic diversification, and multi-channel distribution (retail, e-commerce, foodservice, institutional), supported by innovation in health-focused products and premiumization.- Primary revenue streams: branded retail sales of dairy & plant-based products, bottled and flavored waters, and infant/medical nutrition formulas and nutritional solutions.
- Channels to market: supermarkets, convenience stores, online platforms, pharmacies (for Specialized Nutrition), and foodservice partners.
- Value drivers: product innovation, pricing management, cost-savings programs, portfolio premiumization, and geographic mix toward higher-growth emerging markets.
- Brand premiums and SKU mix - higher-margin specialty and plant-based offerings lift average selling price.
- Scale purchasing and manufacturing efficiencies to protect margins.
- Tailored go-to-market in markets with strong infant nutrition demand and water consumption patterns.
| Metric | 2024 / End-2024 | 2025 |
|---|---|---|
| Sales (total) | €27.4 billion | - |
| Recurring operating margin | - | 13.2% |
| Free cash flow | - | €1.2 billion |
| Net debt (end period) | €8.6 billion (Dec 31, 2024) | €9.1 billion |
| Bond issuance | - | €800 million, 8‑year, 3.438% coupon (listed on Euronext Paris) |
| Segment | Estimated Sales (2024) | Share of Total |
|---|---|---|
| Essential Dairy & Plant-Based | €14.25 billion | ≈52% |
| Specialized Nutrition | €9.05 billion | ≈33% |
| Waters | €4.10 billion | ≈15% |
- Recurring operating margin of 13.2% in 2025 reflects operational improvements and pricing/mix benefits.
- Free cash flow of €1.2bn in 2025 supports dividends, debt servicing and selective M&A.
- Net debt rose to €9.1bn in 2025 from €8.6bn at end‑2024, driven mainly by the May 2025 dividend payment, partially offset by strong cash generation.
- The €800m bond (8‑year, 3.438% coupon) issued and listed on Euronext Paris in 2025 underscores market confidence in Danone's cash generation and credit profile.
Danone S.A. (BN.PA): How It Makes Money
Danone operates as a diversified global food & beverage group with leading positions in dairy & plant-based products, bottled waters, and infant nutrition. The company monetizes through branded product sales across four global segments (Essential Dairy & Plant-Based, Specialized Nutrition, Waters, and other services), premium pricing supported by strong brands, scale-driven manufacturing and distribution, and recurring retail and foodservice contracts.- Market positions: global leader in dairy & plant‑based; #2 in packaged waters and infant nutrition.
- 2025 guidance: like‑for‑like sales growth projected at 3%-5%; recurring operating income expected to outpace sales growth.
- Operational focus: margin expansion via SKU rationalization, pricing, cost savings and supply‑chain optimization.
| Metric (2025) | Value |
|---|---|
| Recurring operating margin | 13.2% |
| Free cash flow | €1.2 billion |
| Net debt (end of period) | €9.1 billion |
| Net debt (Dec 31, 2024) | €8.6 billion |
| Bond issuance | €800 million, 8‑year, 3.438% coupon (listed on Euronext Paris) |
| Like‑for‑like sales growth guidance | 3%-5% |
- Primary revenue drivers:
- Packaged dairy & plant‑based products - largest revenue share, high gross margins on branded SKUs.
- Bottled waters - scale and emerging-market growth; price/mix improvements.
- Infant & specialized nutrition - resilient demand and higher ASPs (average selling prices).
- Geographic mix - stronger pricing power in developed markets, volume growth in emerging markets.

Danone S.A. (BN.PA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.